IntriCon Corporation Capex/Depreciation

Capex/Depreciation of IIN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Capex/Depreciation growth rates and interactive chart.


Highlights and Quick Summary

  • Capex/Depreciation for the quarter ending December 30, 2020 was -0.81 (a -6.83% decrease compared to previous quarter)
  • Year-over-year quarterly Capex/Depreciation decreased by -55.33%
  • Annual Capex/Depreciation for 2020 was -0.79 (a -52.45% decrease from previous year)
  • Annual Capex/Depreciation for 2019 was -1.65 (a -8.52% decrease from previous year)
  • Annual Capex/Depreciation for 2018 was -1.8 (a 77.84% increase from previous year)
  • Twelve month Capex/Depreciation ending December 30, 2020 was -0.79 (a -3.48% decrease compared to previous quarter)
  • Twelve month trailing Capex/Depreciation decreased by -49.93% year-over-year
Trailing Capex/Depreciation for the last four month:
30 Dec '20 29 Sep '20 29 Jun '20 30 Mar '20
-0.79 -0.81 -1.13 -1.57
Visit stockrow.com/IIN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Capex/Depreciation of IntriCon Corporation

Most recent Capex/Depreciationof IIN including historical data for past 10 years.

Interactive Chart of Capex/Depreciation of IntriCon Corporation

IntriCon Corporation Capex/Depreciation for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 -0.81 -0.87 -0.24 -1.82 -0.79
2019 -1.12 -2.59 -1.71 -1.18 -1.65
2018 -2.13 -2.71 -1.49 -0.74 -1.8
2017 -2.28 -0.66 -0.64 -0.49 -1.01
2016 -0.38 -0.57 -1.2 -1.26 -0.84
2015 -2.35 -2.72 -2.29 -1.68 -2.27
2014 -0.93 -0.59 -0.76 -0.39 -0.67
2013 -0.81 -0.39 -0.17 -0.18 -0.38
2012 -0.55 -0.73 -1.19 -0.74 -0.81
2011 -1.95 -1.72 -0.65 -0.32 -1.14
2010 -1.15 -0.61 -0.44 -0.7

Business Profile of IntriCon Corporation

Sector: Healthcare
Industry: Medical Instruments & Supplies
IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. It offers micro-miniature products, microelectronics, micro-mechanical assemblies, high-precision injection-molded plastic components, and assemblies and software solutions for medical devices, hearing healthcare, and professional audio communication devices markets. The company also provides micro coils for surgical navigation clinical applications, such as interventional pulmonology, and electrophysiology; joint engineering and manufacturing services for complex medical devices, including catheters covering a range of applications for cardiology, peripheral vascular, neurology, radiology, and pulmonology; bubble sensors and flow restrictors that monitor and control the flow of fluid in an intravenous infusion system; and safety needle products for original equipment manufacturing customers. In addition, it offers professional audio headset products used for emergency response needs in the fire, law enforcement, safety, aviation, and military markets; and a line of miniature ear-and head-worn devices used by performers and support staff in the music and stage performance markets. The company sells its hearing device products, and medical and professional audio communications products directly to hearing instrument manufacturers, distributors, and partnerships; and microphone products to the radio communication and professional audio industries, as well as markets and sells hearing aid devices directly to consumers through direct mail advertising, Internet, and call center. The company was formerly known as Selas Corporation of America and changed its name to IntriCon Corporation. The company was incorporated in 1930 and is headquartered in Arden Hills, Minnesota.